NCT06431789View on ClinicalTrials.gov

Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

April 30, 2026

Conditions
Gene PolymorphismEdoxabanRenal Insufficiency
Trial Locations (1)

250014

RECRUITING

First Affiliated Hospital of Shandong First Medical University ( Qianfoshan Hospital of Shandong Province ), Jinan

All Listed Sponsors
collaborator

Qianfoshan Hospital

OTHER

lead

Yi Han

OTHER